-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Acuitas Investments LLC Makes New $287,000 Investment in Semler Scientific, Inc. (OTCMKTS:SMLR)
Acuitas Investments LLC Makes New $287,000 Investment in Semler Scientific, Inc. (OTCMKTS:SMLR)
Acuitas Investments LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,800 shares of the medical equipment provider's stock, valued at approximately $287,000. Acuitas Investments LLC owned about 0.09% of Semler Scientific at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Legal Advantage Investments Inc. increased its position in shares of Semler Scientific by 15.0% during the first quarter. Legal Advantage Investments Inc. now owns 19,119 shares of the medical equipment provider's stock worth $948,000 after acquiring an additional 2,500 shares during the period. Anchor Capital Advisors LLC acquired a new position in Semler Scientific in the first quarter valued at $1,573,000. Cannon Global Investment Management LLC acquired a new position in Semler Scientific in the first quarter valued at $362,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Semler Scientific during the first quarter worth about $275,000. Finally, Financial Management Professionals Inc. boosted its stake in shares of Semler Scientific by 197.1% during the first quarter. Financial Management Professionals Inc. now owns 3,013 shares of the medical equipment provider's stock worth $149,000 after buying an additional 1,999 shares during the period. 44.69% of the stock is currently owned by institutional investors and hedge funds.
Get Semler Scientific alerts:Semler Scientific Trading Up 18.8 %
Shares of OTCMKTS SMLR opened at $39.50 on Thursday. The firm's 50-day moving average is $29.71 and its 200-day moving average is $45.49. Semler Scientific, Inc. has a 1 year low of $27.02 and a 1 year high of $153.21. The firm has a market capitalization of $268.21 million, a PE ratio of 24.53 and a beta of 0.89.
Semler Scientific (OTCMKTS:SMLR – Get Rating) last issued its earnings results on Monday, May 2nd. The medical equipment provider reported $0.41 EPS for the quarter, missing the consensus estimate of $0.51 by ($0.10). Semler Scientific had a return on equity of 30.85% and a net margin of 24.08%. The business had revenue of $14.02 million for the quarter, compared to analyst estimates of $14.82 million. As a group, equities research analysts anticipate that Semler Scientific, Inc. will post 1.37 earnings per share for the current fiscal year.Analyst Upgrades and Downgrades
Separately, B. Riley dropped their target price on shares of Semler Scientific from $70.00 to $60.00 in a report on Tuesday, May 3rd.
About Semler Scientific
(Get Rating)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Energy Transfer Is A Value Among High-Yield Energy Infrastructure
- Devon Energy Looks Attractive if You Look Past the Headlines
- 3 Low Priced Stocks With Good Growth Prospects
- Warner Brothers Discovery is a Powerhouse Entertainment Play
- The Institutions Are Buying Under Armor Again
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
Acuitas Investments LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,800 shares of the medical equipment provider's stock, valued at approximately $287,000. Acuitas Investments LLC owned about 0.09% of Semler Scientific at the end of the most recent reporting period.
根據Acuitas Investments LLC最近提交給美國證券交易委員會(Securities And Exchange Commission)的13F文件，Acuitas Investments LLC在第一季度購買了Semler Science，Inc.(OTCMKTS：SMLR-GET Rating)的新股票頭寸。該基金購買了這家醫療設備供應商的5,800股股票，價值約28.7萬美元。在最近的報告期結束時，Acuitas Investments LLC擁有Semler Science約0.09%的股份。
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Legal Advantage Investments Inc. increased its position in shares of Semler Scientific by 15.0% during the first quarter. Legal Advantage Investments Inc. now owns 19,119 shares of the medical equipment provider's stock worth $948,000 after acquiring an additional 2,500 shares during the period. Anchor Capital Advisors LLC acquired a new position in Semler Scientific in the first quarter valued at $1,573,000. Cannon Global Investment Management LLC acquired a new position in Semler Scientific in the first quarter valued at $362,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Semler Scientific during the first quarter worth about $275,000. Finally, Financial Management Professionals Inc. boosted its stake in shares of Semler Scientific by 197.1% during the first quarter. Financial Management Professionals Inc. now owns 3,013 shares of the medical equipment provider's stock worth $149,000 after buying an additional 1,999 shares during the period. 44.69% of the stock is currently owned by institutional investors and hedge funds.
其他幾家機構投資者和對衝基金也改變了他們在該股的頭寸。Legal Advantage Investments Inc.在第一季度將其在Semler Science的股票頭寸增加了15.0%。在此期間，Legal Advantage Investments Inc.增持了2,500股股票，目前持有19,119股這家醫療設備供應商的股票，價值948,000美元。Anch Capital Advisors LLC在第一季度收購了Semler Science的一個新頭寸，價值1,573,000美元。Canon Global Investment Management LLC在第一季度收購了Semler Science的一個新頭寸，價值36.2萬美元。Mesirow Financial Investment Management Inc.在第一季度收購了Semler Science價值約275,000美元的新股。最後，金融管理專業公司在第一季度增持了賽姆勒科學公司197.1%的股份。金融管理專業人士公司在此期間又購買了1,999股，現在擁有這家醫療設備提供商的3,013股股票，價值149,000美元。44.69%的股票目前由機構投資者和對衝基金持有。
Semler Scientific Trading Up 18.8 %
塞姆勒科學公司股價上漲18.8%
Shares of OTCMKTS SMLR opened at $39.50 on Thursday. The firm's 50-day moving average is $29.71 and its 200-day moving average is $45.49. Semler Scientific, Inc. has a 1 year low of $27.02 and a 1 year high of $153.21. The firm has a market capitalization of $268.21 million, a PE ratio of 24.53 and a beta of 0.89.
週四，OTCMKTS SMLR的股價開盤報39.50美元。該公司的50日移動均線切入位為29.71美元，200日移動均線切入位為45.49美元。塞姆勒科學公司的一年低點為27.02美元，一年高位為153.21美元。該公司市值為2.6821億美元，市盈率為24.53倍，貝塔係數為0.89。
Analyst Upgrades and Downgrades
分析師升級和下調評級
Separately, B. Riley dropped their target price on shares of Semler Scientific from $70.00 to $60.00 in a report on Tuesday, May 3rd.
另外，B.萊利在5月3日星期二的一份報告中將Semler Science的目標價從70.00美元下調至60.00美元。
About Semler Scientific
關於塞姆勒科學公司
(Get Rating)
(獲取評級)
Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Semler Science，Inc.提供技術解決方案，以提高美國醫療保健提供者的臨牀效果和效率。該公司的產品包括QuantaFlo，這是一種四分鐘的辦公室內血液流動測試，使醫療保健提供者能夠使用血流測量作為患者血管狀況檢查的一部分。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
- Energy Transfer Is A Value Among High-Yield Energy Infrastructure
- Devon Energy Looks Attractive if You Look Past the Headlines
- 3 Low Priced Stocks With Good Growth Prospects
- Warner Brothers Discovery is a Powerhouse Entertainment Play
- The Institutions Are Buying Under Armor Again
- 免費獲取StockNews.com關於Semler Science(SMLR)的研究報告
- 能源轉移是高產出能源基礎設施的價值所在
- 如果你不去看頭條新聞，德文能源看起來很有吸引力
- 3只具有良好增長前景的低價股票
- 華納兄弟探索是Powerhouse娛樂公司的一部戲劇
- 這些機構再次在Armor下買入
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).
想看看其他對衝基金持有SMLR的情況嗎？訪問HoldingsChannel.com獲取Semler Science，Inc.(OTCMKTS：SMLR-GET Rating)的最新13F文件和內幕交易。
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
接受《塞姆勒科技日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Semler Science及相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧